Brentuximab + Ketoconazole Interaction
Unknowninteraction on record
Description
7.1 Effect of Other Drugs on ADCETRIS CYP3A4 Inhibitors: Co-administration of ADCETRIS with ketoconazole, a potent CYP3A4 inhibitor, increased exposure to MMAE [see Clinical Pharmacology (12.3) ], which may increase the risk of adverse reaction.
Source: FDA drug label - brentuximab vedotin